Rounds Podcast: Half of America has no cardiologist — software bridges that gap with AccurKardia CEO Juan C. Jimenez
Juan C. Jimenez addresses the heart care crisis in the United States where half of all counties have no specialist to read heart scans. There are more monitors than ever but less time to look at the data. Software must... Read More →
Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization
SALT LAKE CITY, Feb. 24, 2026 /PRNewswire/ — Xenocor, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the new Xenocor Saberscope®, a single-use 5mm articulating laparoscope designed for high definition (HD) visualization during minimally invasive... Read More →
Real-time intraoperative confocal laser endomicroscopy with on-site neuropathologist consultation for glioma margin assessment: illustrative case featuring VPIX Medical
This report presents an illustrative case demonstrating a practical collaborative workflow that integrates CLE with on-site neuropathologist consultation for real-time margin assessment during glioma resection. We used the cCeLL-In vivo system (VPIX Medical Inc.), a handheld CLE device with US... Read More →
AptaBLE: a deep learning platform for aptamer generation and analysis featuring Atom Bioworks
Abstract Aptamers are single-stranded oligonucleotides that bind molecular targets with high affinity and specificity. However, their discovery remains time-consuming, expensive, and susceptible to experimental biases. Here we present AptaBLE, a deep learning framework for predicting aptamer-protein binding. Additionally, we demonstrate... Read More →
Strutless bioresorbable BTK scaffold demonstrates technical success and primary safety in first cases featuring StentIt
Preliminary three-month results from the first five human implantations of StentIt’s resorbable fibrillated scaffold (RFS) reveal a technical success rate of 100% and no device- or procedure-related serious adverse events at 30 days in patients with below-the-knee (BTK) chronic limb-threatening... Read More →
FDA Grants PMA Approval to LimiFlex™ Dynamic Sagittal Tether featuring Empirical Spine
Motion-Preserving Lumbar Spine Surgery – Stabilization Without Fusion for Patients with Degenerative Spondylolisthesis San Carlos, CA — February 18, 2026 /OrthoSpineNews/ — The U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) to the LimiFlex™ Dynamic Sagittal Tether,... Read More →
Acute results of the ASCEND EV study: A new modality of parasternal extravascular implantable cardioverter-defibrillator therapy including antitachycardia pacing featuring AtaCor Medical
Background Extravascular implantable cardioverter-defibrillators (EV-ICDs) are being developed to overcome limitations of current implantable cardioverter-defibrillators (ICDs). The AtaCor parasternal EV-ICD system uses an extravascular lead along the left parasternum to deliver defibrillation and pacing therapy from outside the heart. Objective... Read More →
VB Spine Announces Intent to Acquire Exclusive Rights to Augmedics’ Spine Platform
Transaction will expand VB Spine’s enhanced visualization portfolio to include augmented reality navigation with the Augmedics xvision Spine System® NEW YORK & CHICAGO–(BUSINESS WIRE)–VB Spine LLC (“VB Spine”), the largest privately held spine company, today announced it has entered into... Read More →
Retia Medical Receives FDA 510(k) Clearance for Argos Infinity™, Expanding Cardiovascular Intelligence Across High-Risk Surgical and Critical Care Environments
WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 — Retia Medical today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Argos Infinity™, the company’s cardiovascular intelligence software platform designed for high-risk surgical... Read More →
InVera Medical achieves European CE Mark approval for new vein infusion device
GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ — InVera Medical, an Irish medical technology company, has received European regulatory approval for a new minimally invasive device designed to help physicians deliver treatment more effectively to diseased leg veins, including varicose veins.... Read More →